Australia, Sept. 12 -- DIASORIN S.p.A, owns the trademark (2405952) for 'LIAISON NES' till July 28, 2033.

Status: protected: Registered/protected

Classes: 1 [Chemicals used in science; chemical diagnostic reagents for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic substances, other than for medical use; reagent strips; diagnostic testing materials, other than for medical use; control preparations for in vitro diagnostic testing, screening, confirmation and analysis; diagnostic reagents and chemical reagents for laboratory or research purposes; solutions used in diagnostic test kits for laboratory or research purposes; test strips for laboratory or research purposes; diagnostic preparations for laboratory or research use; diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; diagnostic biomarkers for analytical, research and scientific use; diagnostic preparations for in vitro testing for scientific use; nucleic acids; nucleic acids for scientific purposes.], 5 [Diagnostic preparations for medical and veterinary purposes; diagnostic test reagents for veterinary use; diagnostic test reagents for medical purposes; diagnostic agents for medical use; chemical reagents for medical or veterinary purposes; diagnostic kits comprising bioreagents; diagnostic test kits comprising reagents and assays; diagnostic testing materials for medical use; medical diagnostic test strips; testing preparations for medical use; medical diagnostic assays; in vitro medical diagnostic tests; in vitro medical diagnostic assays; in vitro medical diagnostic test kits; in vitro medical diagnostic test strips; in vitro medical diagnostic reagents; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of viruses and infections; reagents and test strips for use as indicators of diseases, of antigens and of antibodies; immunoassay reagents for medical use; biological and chemical preparations and reagents for medical or veterinary use; biochemical preparations for medical or veterinary purposes; bacterial preparations for medical and veterinary use; nucleic acid sequences for medical and veterinary purposes; reagents for the detection of pathogens responsible for respiratory infections, such as influenza, COVID-19 and Group A Streptococcus; reagents for the detection of pathogens responsible for sexually transmitted infections.], 9 [Software applications for diagnostic; computer software for medical diagnostics, diagnostic apparatus not for medical purpose; testing apparatus for diagnostic purposes [other than medical]; portable and cloud-connected POC (Point of care) immunodiagnostic software platform; computer software and hardware for the design, creation and control of tools for medical diagnostics; data-processing software; apparatus, equipment, hardware and computers for diagnostics; data storage, processing and transmission apparatus for diagnostic purpose; readers [data processing equipment] for diagnostic purpose; tablets used for test and diagnostic purpose; video monitors; parts and fittings for the aforementioned goods all applied in the diagnostic field; testing apparatus not for medical purposes; measuring or testing machines and instruments for diagnostic purpose, other than for medical use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids.] and 10 [Testing apparatus for medical purposes; diagnostic apparatus for medical purposes; tools for medical diagnostics; medical devices for diagnostics; medical testing equipment; apparatus for use in medical analysis; electronic analyzers for medical purposes; apparatus for taking blood samples; apparatus for taking body fluid samples; Point of Care (POC) diagnostic, examination, and monitoring equipment; Point of care (POC) apparatus for carrying-out diagnostic tests for medical purposes; diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2; diagnostic apparatus for the identification of virus, bacterial infections and infectious diseases; diagnostic imaging apparatus for medical purposes; laboratory apparatus for medical diagnostic purposes; medical diagnostic apparatus for testing for viruses; apparatus for DNA and RNA testing for medical purposes; syringes for injections; extraction syringes; disposable hypodermic syringes for medical use; medical syringe devices; diagnostic apparatus for the identification of respiratory infections, such as influenza, SARS-CoV-2 and Group A Streptococcus; diagnostic apparatus for the identification of sexually transmitted infections; molecular platform designed for the detection of pathogens causing infectious diseases through PCR nucleic acid amplification technology.]

Type of Mark: Word

Date of Acceptance: July 4

Registration Advertised: Sept. 11

For further details contact Corrs Chambers Westgarth and Jacobacci & Partners S.p.A .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2405952.

Disclaimer: Curated by HT Syndication.